ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Total assets, 2025
- $5.0B
- YoY, 2025
- +17.1%
- 5-year CAGR
- +7.8%
- 10-year CAGR
- +13.6%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $5.0B | +17.1% |
| 2024 | $4.2B | +10.7% |
| 2023 | $3.8B | +8.0% |
| 2022 | $3.5B | −2.7% |
| 2021 | $3.6B | +6.9% |
| 2020 | $3.4B | +42.2% |
| 2019 | $2.4B | +52.1% |
| 2018 | $1.6B | −21.1% |
| 2017 | $2.0B | +58.0% |
| 2016 | $1.3B | −8.9% |
| 2015 | $1.4B | +28.4% |
| 2014 | $1.1B | +156.7% |
| 2013 | $421M | +46.3% |
| 2012 | $288M | +2.0% |
| 2011 | $282M | −28.3% |
| 2010 | $393M | −18.3% |
| 2009 | $481M | — |